Provided by Tiger Trade Technology Pte. Ltd.

NexImmune, Inc.

0.0001
+0.00019900.00%
Volume:7.52K
Turnover:0.75
Market Cap:139.47
PE:0.00
High:0.0001
Open:0.0001
Low:0.0001
Close:0.0000
52wk High:1.01
52wk Low:0.0000
Shares:1.39M
Float Shares:1.18M
Volume Ratio:3.80
T/O Rate:0.64%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-17.3890
EPS(LYR):-30.8198
ROE:-232.97%
ROA:-72.69%
PB:0.00
PE(LYR):0.00

Loading ...

Company Profile

Company Name:
NexImmune, Inc.
Exchange:
EXPERT
Establishment Date:
2011
Employees:
6
Office Location:
9119 Gaither Road,Gaithersburg,Maryland,United States
Zip Code:
20877
Fax:
- -
Introduction:
NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's product candidates include NEXI-001, an allogeneic cell therapy, which is in Phase I/II clinical trials for the treatment of patients with acute myeloid leukemia; NEXI-002, an autologous cell therapy that is in Phase I/II clinical trials for the treatment of patients with relapsed and/or refractory in multiple myeloma; and NEXI-003, a candidate targeted against HPV-associated malignancies, which is in preclinical stage. The company was incorporated in 2011 and is headquartered in Gaithersburg, Maryland.